GE HealthCare Technologies (NASDAQ:GEHC) reported third-quarter results in line with expectations on Wednesday and raised the lower end of its full-year profit forecast, though shares slipped 2% in premarket trading.
The medical technology group posted adjusted earnings of $1.07 per share, roughly matching the $1.05 analyst consensus, while revenue climbed 6% year-over-year to $5.14 billion, slightly above expectations of $5.08 billion.
Organic revenue growth reached 4%, supported by solid demand across EMEA and the U.S., according to the company. Adjusted EBIT came in at $761 million, down modestly from $795 million in the same quarter last year.
“We delivered robust orders with growth across all segments in the third quarter. This was led by customer demand for our differentiated solutions and a healthy capital equipment environment,” said Peter Arduini, President and CEO of GE HealthCare.
Looking ahead, the company raised the lower end of its full-year 2025 adjusted EPS guidance to $4.51–$4.63, compared with the prior range of $4.43–$4.63, and above the $4.52 analyst consensus. GE HealthCare reaffirmed all other financial targets.
Despite the slightly softer EBIT figure, the results underscored continued resilience in global healthcare spending and steady demand for diagnostic imaging and patient monitoring equipment — key growth areas for the company.